Poland· PL-100503312
Polpril Nebi
A ace inhibitors, other combinations product containing ramiprilum + nebivololi hydrochloridum, registered in Poland by Zakłady Farmaceutyczne POLPHARMA S.A.. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Ramiprilum + nebivololi hydrochloridum is registered in 4 of 19 countries.
Countries holding a registration under ATC C09BX (ace inhibitors, other combinations), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Ramiprilum + nebivololi hydrochloridum · ATC C09BX
4 / 19 countries
- Belgiumprice
- Czechiaprice
- Ireland
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Ramiprilum + Nebivololi hydrochloridum
- Manufacturer
- Zakłady Farmaceutyczne POLPHARMA S.A.
- Country
- Poland (PL)
- ATC code
- C09BX
- ATC class
- ACE inhibitors, other combinations
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991593933
- gtin05909991593940
- gtin05909991593957
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ramiprilum + nebivololi hydrochloridum in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNEBOTRUVMenarini International Operations Luxembourg S.A., Luxembourg
- SpainTWILEV 10 MG / 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULAMenarini International Operations Luxembourg S.A.
- IrelandTwilev 10 mg/5 mg film-coated tabletsMenarini International Operations Luxembourg S.A.
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Twilev
- Bulgaria · Полпрен, Туилев
- Czechia · Nebotruv
- Estonia · Twilev
- Spain · Twilev
- France · Nebopek
- Greece · Twilev
- Croatia · Twilev
- Ireland · Twilev
- Italy · Ezerdence
- Lithuania · Twilev
- Latvia · Twilev
- Portugal · Twilev
- Romania · Twilev
- Slovenia · Ezerdence
- Slovakia · Twilev
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c98a5a20-f273-4ef7-9413-22be371fea8a GET /v1/drugs/c98a5a20-f273-4ef7-9413-22be371fea8a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki twarde",
"source": "urpl",
"strength": "2,5 mg + 5 mg",
"packaging": "05909991593933 ¦ Rp ¦ 165693\n30 kaps.\n05909991593940 ¦ Rp ¦ 165694\n60 kaps.\n05909991593957 ¦ Rp ¦ 165695\n90 kaps.",
"substance": "Ramiprilum 2.5 mg + Nebivololi hydrochloridum 5.45 mg",
"common_name": "Ramiprilum + Nebivololi hydrochloridum",
"pl_product_id": "100503312",
"pozwolenie_nr": "29514",
"auth_procedure": "DCP",
"authorisation_validity": "2031-02-12"
}See everything about ramiprilum + nebivololi hydrochloridum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.